SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Ukraine is attacking Wildberries, Russia’s Amazon, to bring the war into everyday life

Cyber incident at crypto company Bits of Gold: customers' personal details may have leaked

Israel is trying to shape what AI chatbots say about Gaza and the IDF

“Sell everything you have vested”

Buzz

Most popular

Daily

Weekly

1

Anthropic closes in on $7 billion Decart deal after beating Nvidia to the table

2

Palo Alto’s CEO bought the dip. Five months later, his $10 million bet is worth $26 million

3

Why Anthropic is willing to pay $6 billion for Decart

4

The 50 most promising Israeli startups - 2026

5

Anthropic in talks to acquire Israeli AI startup Decart for $6 billion

ADHD

4 stories about ADHD

“There are so few female founders; this has to be put in the past”

21.08.24|Ariela Karmel

Eve Mamane, Co-Founder and CRO of mental health startup Agave Health, spoke to CTech about founding her first venture, the need to normalize female founders, and why the tech industry must eliminate outdated limitations on women in leadership roles

Israeli app launches in the U.S. and Israel, helping parents of ADHD children

15.01.24|James Spiro

Pery uses clinical data and LLMs to provide advice and analysis for parents managing children diagnosed with attention deficit hyperactivity disorder

“There is a $5 billion opportunity in the ADHD market”

MindTension has raised a total of $2 million for its tool helping diagnose and treat optimization of ADHD and related mental health comorbidities

מטה טבע פתח תקווה

Teva Reaches Confidential Patent Settlement with Neos

The agreement will enable Teva to manufacture and sell a generic version of Neos’ ADHD drug Cotempla as of 2026